ACADIA Pharmaceuticals Ownership | Who Owns ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals Ownership Summary
ACADIA Pharmaceuticals is owned by 93.21% institutional investors, 0.53% insiders, and 6.26% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 26.02% of ACAD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.32% of its assets in ACADIA Pharmaceuticals shares.
ACAD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ACADIA Pharmaceuticals | 93.21% | 0.53% | 6.26% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 42.88M | 26.02% | $696.77M |
| Vanguard group | 13.71M | 8.32% | $222.82M |
| Rtw investments, lp | 13.71M | 8.32% | $222.75M |
| Blackrock | 12.06M | 7.32% | $196.01M |
| State street | 5.80M | 3.52% | $94.26M |
| D. e. shaw | 2.93M | 1.78% | $47.69M |
| Geode capital management | 2.84M | 1.73% | $46.24M |
| Marshall wace, llp | 2.77M | 1.68% | $45.08M |
| Fred alger management | 2.70M | 1.64% | $43.95M |
| Palo alto investors lp | 2.42M | 1.47% | $39.31M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Baker bros. advisors lp | 42.88M | 8.90% | $696.77M |
| Palo alto investors lp | 2.42M | 4.55% | $39.31M |
| Finepoint capital lp | 905.38K | 4.18% | $14.71M |
| Birchview capital, lp | 250.40K | 3.77% | $4.07M |
| Rtw investments, lp | 13.71M | 3.45% | $222.75M |
| Tang capital management | 1.50M | 2.48% | $24.38M |
| Nan fung group | 102.98K | 1.79% | $1.67M |
| Alphacentric advisors | 100.00K | 1.20% | $1.63M |
| Jgp global gestao de recursos ltda. | 36.74K | 0.76% | $597.02K |
| Rice hall james & associates | 742.93K | 0.72% | $12.07M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Marshall wace, llp | 2.77M | 0.06% | 2.25M |
| Norges bank | 1.45M | 0.00% | 1.45M |
| Jacobs levy equity management | 1.36M | 0.09% | 1.36M |
| Tang capital management | 1.50M | 2.48% | 981.10K |
| Morgan stanley | 2.39M | 0.00% | 928.09K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 920.09K | 0.00% | -3.08M |
| Fmr | 2.37M | 0.00% | -1.63M |
| Ecor1 capital | - | - | -1.35M |
| Emerald advisers | 808.83K | 0.55% | -842.29K |
| Pictet asset management sa | 512.69K | 0.01% | -795.07K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.45M | 0.00% | 1.45M | $23.59M |
| Neo ivy capital management | 203.05K | 0.65% | 203.05K | $3.30M |
| Goldman sachs group | 89.80K | 0.00% | 89.80K | $1.46M |
| Mirae asset global etfs | 83.14K | 0.00% | 83.14K | $1.35M |
| Corebridge financial | 64.38K | 0.01% | 64.38K | $1.05M |
Sold Out
| Holder | Change |
|---|---|
| Concord wealth partners | -10.00 |
| Bokf, na | -16.00 |
| Huntington national bank | -50.00 |
| Cornerstone planning group | -50.00 |
| Thurston, springer, miller, herd & titak | -53.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 266 | -3.97% | 154,699,805 | -3.89% | 93 | 0.99% | 127 | -15.89% | 80 | 1.27% |
| Jun 30, 2024 | 275 | -4.51% | 160,951,158 | 0.75% | 97 | 1.04% | 150 | -3.23% | 78 | 5.41% |
| Mar 31, 2024 | 288 | -2.04% | 159,752,773 | 0.26% | 96 | 1.02% | 155 | -4.32% | 74 | 1.37% |
| Dec 31, 2023 | 294 | 11.36% | 159,346,491 | 2.98% | 97 | 1.10% | 162 | 23.66% | 73 | -1.35% |
| Sep 30, 2023 | 264 | 8.20% | 154,733,497 | -2.72% | 94 | 0.99% | 131 | 16.96% | 74 | -3.90% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.86M | 2.32% | -29.58K |
| SPDR® S&P Biotech ETF | 3.15M | 1.90% | 34.88K |
| Vanguard Small Cap Index | 3.12M | 1.88% | 6.10K |
| iShares Russell 2000 ETF | 3.07M | 1.84% | -6.89K |
| First Trust NYSE Arca Biotech ETF | 2.64M | 1.59% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.86M | 1.12% | -5.20K |
| Vanguard Small Cap Growth Index Inv | 1.71M | 1.03% | -5.82K |
| Fidelity Small Cap Index | 1.23M | 0.74% | -28.97K |
| iShares Biotechnology ETF | 1.16M | 0.70% | -11.77K |
| iShares Russell 2000 Growth ETF | 1.06M | 0.64% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 19, 2024 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | Sell | $173.63K |
| Nov 19, 2024 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | Sell | $68.47K |
| Nov 19, 2024 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Sell | $172.45K |
| Aug 19, 2024 | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | Sell | $148.72K |
| Aug 19, 2024 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | Sell | $145.68K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 3 |
| 2024 Q2 | - | 11 |
| 2024 Q1 | - | 10 |
| 2023 Q4 | - | 6 |
ACAD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools